Pricing Log in Create free account

Cellectar Biosciences, Inc. (CLRB) vs Vyome Holdings, Inc. (HIND)

Cellectar Biosciences, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and Vyome Holdings, Inc. are of similar size ($11.4M and $10.9M). Cellectar Biosciences, Inc. has the higher net margin (0.00% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Cellectar Biosciences, Inc. leads on 7 and Vyome Holdings, Inc. on 5.

Valuation

Metric CLRB HIND Biotechnology median
P/E n/m n/m 10.26
P/S n/m 87.06 9.18
P/B 0.48 1.55 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.83 n/m 0.65
EV/Sales n/m 124.58 8.98
Earnings yield (395.97%) (222.25%) (34.89%)
Free cash flow yield (137.75%) (49.36%) (24.52%)

Profitability

Metric CLRB HIND Biotechnology median
Gross margin 0.00% 52.77% 65.16%
Operating margin 0.00% (9,184.82%) 0.00%
Net margin 0.00% (8,711.71%) 0.00%
Free cash flow margin 0.00% (4,298.00%) 0.00%
Return on equity (125.99%) (172.10%) (50.12%)
Return on assets (88.70%) (124.23%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLRB HIND Biotechnology median
Revenue growth (TTM) — (67.10%) 6.26%
EPS growth (last fiscal year) 80.07% 99.92% 29.88%
Revenue growth, 5-year CAGR — (50.98%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLRB HIND Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.66 4.37 4.89
Net debt to EBITDA 0.58 0.48 1.01

Dividend

Metric CLRB HIND Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLRB HIND Biotechnology median
Market cap 10.87m 11.44m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack